Global Bronchodilators Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Bronchodilator Market is presumed to reach the market size of nearly USD 35.05 BN by 2030 from USD 23.87 BN in 2022 with a CAGR of 4.92% under the study period 2023 - 2030.

A bronchodilator is a medication that helps to open up or dilate the air passages in the lungs, making it easier to breathe. They are typically used to treat asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders that cause difficulty breathing. These medicines work by relaxing the muscles that surround the airways in the lungs, which allows the air passages to widen and improve airflow.

Market Dynamics:

The bronchodilator market is experiencing significant growth due to the escalating prevalence of respiratory disorders like asthma, COPD, and bronchitis. With the global incidence of these conditions on the rise, the demand for efficient medications is also increasing. The growing awareness about the importance of maintaining good respiratory health is another factor driving this market. People are becoming more aware of the risks associated with respiratory disorders and are taking steps to prevent and manage these conditions, which includes the use of bronchodilator medications. The development of new drug delivery technologies is also driving the market. Inhalation devices such as metered-dose inhalers, dry powder inhalers, and nebulizers are becoming more advanced, making it more convenient and easy for patients to administer these medications. The global geriatric population is increasing, which is driving the demand for bronchodilator medications. The elderly are more susceptible to respiratory disorders and often require long-term treatment with bronchodilators to manage their symptoms. Pharmaceutical companies are investing heavily in research and development to develop new and more effective medications. This is driving innovation in the field and leading to the development of new effective treatments.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of bronchodilator. The growth and trends of bronchodilator industry provide a holistic approach to this study.

Market Segmentation:

This section of the bronchodilator market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

Beta-Adrenergic Bronchodilators
Xanthine Derivatives
Anticholinergic Bronchodilators

By Route Of Administration

Oral
Nasal (Inhalable)
Injectable

By Disease

Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Bronchodilator market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the bronchodilator market include F. Hoffmann-La Roche Ltd, GSK plc., Johnson & Johnson Services, Inc., AstraZeneca, Siemens Healthcare GmbH, Abbott, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Quest Diagnostics Incorporated., FOUNDATION MEDICINE, INC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

Product Code: VMR112111165

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . BRONCHODILATOR - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Class
- 3.7.2 Market Attractiveness Analysis By Route Of Administration
- 3.7.3 Market Attractiveness Analysis By Disease
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BRONCHODILATOR MARKET ANALYSIS BY DRUG CLASS

5.1 Overview by Drug Class
5.2 Historical and Forecast Data
5.3 Analysis by Drug Class
5.4 Beta-Adrenergic Bronchodilators Historic and Forecast Sales by Regions
5.5 Xanthine Derivatives Historic and Forecast Sales by Regions
5.6 Anticholinergic Bronchodilators Historic and Forecast Sales by Regions

6 . GLOBAL BRONCHODILATOR MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

6.1 Overview by Route Of Administration
6.2 Historical and Forecast Data
6.3 Analysis by Route Of Administration
6.4 Oral Historic and Forecast Sales by Regions
6.5 Nasal (Inhalable) Historic and Forecast Sales by Regions
6.6 Injectable Historic and Forecast Sales by Regions

7 . GLOBAL BRONCHODILATOR MARKET ANALYSIS BY DISEASE

7.1 Overview by Disease
7.2 Historical and Forecast Data
7.3 Analysis by Disease
7.4 Asthma Historic and Forecast Sales by Regions
7.5 Chronic Obstructive Pulmonary Disease (COPD) Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL BRONCHODILATOR MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE BRONCHODILATOR COMPANIES

9.1. Bronchodilator Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF BRONCHODILATOR INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. F. Hoffmann-La Roche Ltd
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. GSK plc.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Johnson & Johnson Services Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. AstraZeneca
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Siemens Healthcare GmbH
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Abbott
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Bio-Rad Laboratories Inc.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Thermo Fisher Scientific
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Quest Diagnostics Incorporated.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. FOUNDATION MEDICINE INC.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies